Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Notes Payables (2016 - 2025)

INVO Fertility has reported Notes Payables over the past 16 years, most recently at $149293.0 for Q3 2025.

  • Quarterly Notes Payables fell 98.0% to $149293.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $149293.0 through Sep 2025, down 98.0% year-over-year, with the annual reading at $880000.0 for FY2024, 68.16% down from the prior year.
  • Notes Payables was $149293.0 for Q3 2025 at INVO Fertility, down from $2.9 million in the prior quarter.
  • Over five years, Notes Payables peaked at $7.5 million in Q3 2024 and troughed at $149293.0 in Q3 2025.
  • The 5-year median for Notes Payables is $1.9 million (2023), against an average of $2.3 million.
  • Year-over-year, Notes Payables soared 375.45% in 2021 and then plummeted 98.0% in 2025.
  • A 5-year view of Notes Payables shows it stood at $453406.0 in 2021, then surged by 68.2% to $762644.0 in 2022, then surged by 262.41% to $2.8 million in 2023, then tumbled by 68.16% to $880000.0 in 2024, then plummeted by 83.03% to $149293.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Notes Payables are $149293.0 (Q3 2025), $2.9 million (Q2 2025), and $6.5 million (Q1 2025).